Omeros Corporation (OMER): Price and Financial Metrics
Omeros Corporation (OMER)
Today's Latest Price: $10.54 USD
Updated Oct 27 6:55pm
Add OMER to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
OMER Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for OMER is -0.62 -- better than only 5.58% of US stocks.
- OMER's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 5.74% of US stocks.
- As for revenue growth, note that OMER's revenue has grown 33.51% over the past 12 months; that beats the revenue growth of 86.1% of US companies in our set.
- Stocks that are quantitatively similar to OMER, based on their financial statements, market capitalization, and price volatility, are DNN, CLSN, AVEO, PTCT, and BLCM.
- Visit OMER's SEC page to see the company's official filings. To visit the company's web site, go to www.omeros.com.
OMER Stock Price Chart Interactive Chart >
OMER Price/Volume Stats
| Current price | $10.54 | 52-week high | $25.46 |
| Prev. close | $10.22 | 52-week low | $8.50 |
| Day low | $10.02 | Volume | 560,000 |
| Day high | $10.65 | Avg. volume | 916,019 |
| 50-day MA | $11.25 | Dividend yield | N/A |
| 200-day MA | $13.45 | Market Cap | 574.62M |
Omeros Corporation (OMER) Company Bio
Omeros Corporation is a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded in 1994 and is based in Seattle, Washington.
Loading social stream, please wait...